233 research outputs found
SosA inhibits cell division in Staphylococcus aureus in response to DNA damage.
Inhibition of cell division is critical for viability under DNA-damaging conditions. DNA damage induces the SOS response that in bacteria inhibits cell division while repairs are being made. In coccoids, such as the human pathogen, Staphylococcus aureus, this process remains poorly studied. Here, we identify SosA as the staphylococcal SOS-induced cell division inhibitor. Overproduction of SosA inhibits cell division, while sosA inactivation sensitizes cells to genotoxic stress. SosA is a small, predicted membrane protein with an extracellular C-terminal domain in which point mutation of residues that are conserved in staphylococci and major truncations abolished the inhibitory activity. In contrast, a minor truncation led to SosA accumulation and a strong cell division inhibitory activity, phenotypically similar to expression of wild-type SosA in a CtpA membrane protease mutant. This suggests that the extracellular C-terminus of SosA is required both for cell division inhibition and for turnover of the protein. Microscopy analysis revealed that SosA halts cell division and synchronizes the cell population at a point where division proteins such as FtsZ and EzrA are localized at midcell, and the septum formation is initiated but unable to progress to closure. Thus, our findings show that SosA is central in cell division regulation in staphylococci
Exact solution of the six-vertex model with domain wall boundary condition. Critical line between ferroelectric and disordered phases
This is a continuation of the papers [4] of Bleher and Fokin and [5] of
Bleher and Liechty, in which the large asymptotics is obtained for the
partition function of the six-vertex model with domain wall boundary
conditions in the disordered and ferroelectric phases, respectively. In the
present paper we obtain the large asymptotics of on the critical line
between these two phases.Comment: 22 pages, 6 figures, to appear in the Journal of Statistical Physic
Exact solution of the six-vertex model with domain wall boundary conditions. Antiferroelectric phase
We obtain the large asymptotics of the partition function of the
six-vertex model with domain wall boundary conditions in the antiferroelectric
phase region, with the weights a=\sinh(\ga-t), b=\sinh(\ga+t), c=\sinh(2\ga),
|t|<\ga. We prove the conjecture of Zinn-Justin, that as ,
Z_n=C\th_4(n\om) F^{n^2}[1+O(n^{-1})], where \om and are given by
explicit expressions in \ga and , and is the Jacobi theta
function. The proof is based on the Riemann-Hilbert approach to the large
asymptotic expansion of the underlying discrete orthogonal polynomials and on
the Deift-Zhou nonlinear steepest descent method.Comment: 69 pages, 10 figure
Measurement of the B0-anti-B0-Oscillation Frequency with Inclusive Dilepton Events
The - oscillation frequency has been measured with a sample of
23 million \B\bar B pairs collected with the BABAR detector at the PEP-II
asymmetric B Factory at SLAC. In this sample, we select events in which both B
mesons decay semileptonically and use the charge of the leptons to identify the
flavor of each B meson. A simultaneous fit to the decay time difference
distributions for opposite- and same-sign dilepton events gives ps.Comment: 7 pages, 1 figure, submitted to Physical Review Letter
A critical role for muscle ring finger-1 in acute lung injury-associated skeletal muscle wasting
Rationale: Acute lung injury (ALI) is a debilitating condition associated with severe skeletal muscle weakness thatpersists in humans long after lung injury has resolved. The molecular mechanisms underlying this condition are unknown. Objectives: To identify the muscle-specific molecular mechanisms responsible for muscle wasting in a mouse model of ALI. Methods:Changes in skeletal muscle weight, fiber size, in vivo contractile performance, and expression of mRNAs and proteins encoding muscle atrophy-associated genes for muscle ring finger-1 (MuRF1) and atrogin1 were measured. Genetic inactivation of MuRF1 or electroporation-mediated transduction of miRNA-based short hairpin RNAs targeting either MuRF1 or atrogin1 were used to identify their role in ALI-associated skeletal muscle wasting. Measurements and Main Results: Mice with ALI developed profound muscle atrophy and preferential loss of muscle contractile proteins associatedwith reducedmuscle function in vivo. Although mRNA expression of the muscle-specific ubiquitin ligases, MuRF1 and atrogin1, was increased in ALI mice, only MuRF1 protein levels were up-regulated. Consistent with these changes, suppression of MuRF1 by genetic or biochemical approaches prevented muscle fiber atrophy, whereas suppression of atrogin1 expression was without effect. Despite resolution of lung injury and down-regulation of MuRF1 and atrogin1, force generation in ALI mice remained suppressed. Conclusions: These data show that MuRF1 is responsible for mediating muscle atrophy that occurs during the period of active lung injury inALI mice and that, as in humans, skeletal muscle dysfunction persists despite resolution of lung injury
Galaxy Clusters Associated with Short GRBs. II. Predictions for the Rate of Short GRBs in Field and Cluster Early-Type Galaxies
We determine the relative rates of short GRBs in cluster and field early-type
galaxies as a function of the age probability distribution of their
progenitors, P(\tau) \propto \tau^n. This analysis takes advantage of the
difference in the growth of stellar mass in clusters and in the field, which
arises from the combined effects of the galaxy stellar mass function, the
early-type fraction, and the dependence of star formation history on mass and
environment. This approach complements the use of the early- to late-type host
galaxy ratio, with the added benefit that the star formation histories of
early-type galaxies are simpler than those of late-type galaxies, and any
systematic differences between progenitors in early- and late-type galaxies are
removed. We find that the ratio varies from R(cluster)/R(field) ~ 0.5 for n =
-2 to ~ 3 for n = 2. Current observations indicate a ratio of about 2,
corresponding to n ~ 0 - 1. This is similar to the value inferred from the
ratio of short GRBs in early- and late-type hosts, but it differs from the
value of n ~ -1 for NS binaries in the Milky Way. We stress that this general
approach can be easily modified with improved knowledge of the effects of
environment and mass on the build-up of stellar mass, as well as the effect of
globular clusters on the short GRB rate. It can also be used to assess the age
distribution of Type Ia supernova progenitors.Comment: ApJ accepted versio
Measurement of the CP-Violating Asymmetry Amplitude sin2
We present results on time-dependent CP-violating asymmetries in neutral B decays to several CP eigenstates. The measurements use a data sample of about 88 million Y(4S) --> B Bbar decays collected between 1999 and 2002 with the BABAR detector at the PEP-II asymmetric-energy B Factory at SLAC. We study events in which one neutral B meson is fully reconstructed in a final state containing a charmonium meson and the other B meson is determined to be either a B0 or B0bar from its decay products. The amplitude of the CP-violating asymmetry, which in the Standard Model is proportional to sin2beta, is derived from the decay-time distributions in such events. We measure sin2beta = 0.741 +/- 0.067 (stat) +/- 0.033 (syst) and |lambda| = 0.948 +/- 0.051 (stat) +/- 0.017 (syst). The magnitude of lambda is consistent with unity, in agreement with the Standard Model expectation of no direct CP violation in these modes
Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk
BRCA1-associated breast and ovarian cancer risks can be modified by common genetic variants. To identify further cancer risk-modifying loci, we performed a multi-stage GWAS of 11,705 BRCA1 carriers (of whom 5,920 were diagnosed with breast and 1,839 were diagnosed with ovarian cancer), with a further replication in an additional sample of 2,646 BRCA1 carriers. We identified a novel breast cancer risk modifier locus at 1q32 for BRCA1 carriers (rs2290854, P = 2.7×10-8, HR = 1.14, 95% CI: 1.09-1.20). In addition, we identified two novel ovarian cancer risk modifier loci: 17q21.31 (rs17631303, P = 1.4×10-8, HR = 1.27, 95% CI: 1.17-1.38) and 4q32.3 (rs4691139, P = 3.4×10-8, HR = 1.20, 95% CI: 1.17-1.38). The 4q32.3 locus was not associated with ovarian cancer risk in the general population or BRCA2 carriers, suggesting a BRCA1-specific associat
- …